Power Law company profile

BioPharmX

Biotech & Life Sciences · Menlo Park, United States · Founded 2011 · IPO 2015 Thoroughbred

Innovative drug-delivery products through its unique, patented platform technologies for pharmaceutical and otc

Valuation

$1.02B

Market cap · 2026

Revenue

$158M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on BioPharmX's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Korea Investment Partners

Global footprint

Where BioPharmX has talent and traffic

Workforce by country

🇺🇸 United States · Menlo Park HQ

Book a demo for the full country breakdown

Web traffic by country

110 monthly visits
across markets

🇲🇽 Mexico90.9%

Top 1 markets shown

Market sentiment

What the market is saying about BioPharmX

An AI-synthesized read of the highest-engagement posts about BioPharmX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioPharmX on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles